Proximod for rheumatoid arthritis after other treatments fail
This trial tests a new medicine called Proximod for people with moderate to severe rheumatoid arthritis that hasn't improved with other treatments. It aims to see if Proximod can reduce joint pain and swelling better than a placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with rheumatoid arthritis for at least 3 months.
- You have at least 6 tender and 6 swollen joints, and your inflammation blood tests are above a certain level.
- You have taken methotrexate (a common RA medicine) for at least 3 months, with a stable dose for at least 4 weeks.
- You have tried at least one other biologic or targeted RA medicine that didn't work or caused bad side effects.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study and for 9 months after.
- You have no active tuberculosis or other serious infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication (BMS-986454) for people with rheumatoid arthritis who haven't responded well enough to methotrexate. It aims to see if the drug is safe and how it works in the body.
This trial tests an investigational drug for people with moderate-to-severe rheumatoid arthritis who haven't responded well to previous treatments. It aims to see if the drug can reduce joint pain and swelling.
This study tests a new drug, RO7790121, for people with rheumatoid arthritis (RA) who have not gotten better with or could not tolerate common treatments like TNF inhibitors or JAK inhibitors. It aims to see if the drug is safe and can help reduce joint pain and swelling.
This Phase 4 trial studies whether immune-modulator medicines improve symptoms and function in people with rheumatoid arthritis who have knee problems. It may also compare responses in osteoarthritis and healthy volunteers, depending on the group you fit.
This study tests different targeted treatments for adults with rheumatoid arthritis who have already tried other biologic or targeted medications and need a new option. It aims to find which treatment works best for people like you.
This study tests a new medication called AZD1163 for people with rheumatoid arthritis (RA) that hasn't responded well enough to standard treatments. It aims to see if the drug can safely reduce joint swelling and pain.
Hear when a new Rheumatoid Arthrits trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.